Archives

by in
Entry Author Date Location
Cleantech Entrepreneurs—and Sasquatch—Star at Surge Demo Day 05/23/14 Texas
Y Combinator’s Winter 2014 Class: Be Impressed, Don’t Say “Invest” 03/26/14 San Francisco
Dallas Biotech Neos Therapeutics Raises $15.5M for ADHD Drugs 03/05/14 Texas
Nancy Pelosi Meets New Breed of Maker-Entrepreneurs at TechShop 01/22/14 San Francisco
JOBS Act Fallout: Do New Rules Mean Don’t Talk Money on Demo Day? 10/15/13 New York
Fort Worth’s Athlon Energy to Raise $363 Million in IPO 07/29/13 Texas
Is Crowdfunding The Future For Biomedical Research? 07/11/13 National
Zillow Takes Questions via Twitter in Real-Time During Earnings Call 05/08/13 Seattle
SEC’s New Social Media Guidance: Sensible, Fair, Inevitable 04/03/13 National
Fred Wilson Calls Out Enterprise Tech Incumbents, Sees Room for NY Startups 12/19/12 New York
SEC’s Action Against Hastings a Step Backwards 12/07/12 National
Silicon Valley Debates the Do’s and Don’ts of Equity Crowdfunding 09/26/12 San Francisco
CircleUp Brings Crowdfunding, Of a Sort, to Non-Tech Firms 07/02/12 San Francisco
The Wisdom of the Crowd: Social Networking Meets Capital Formation 11/08/11 National
Venture Industry Calls for Rules Changes to Reopen IPO Market 10/20/11 National
Sequenom Inaugurates New Diagnostic Test for Down Syndrome 10/17/11 San Diego
SecondMarket Attempts to Sell Startups on the Value of Letting Employees Trade Their Stock 08/18/11 San Francisco
SEC Accuses Seattle Genetics Employee of Insider Trading 01/21/11 Seattle
Venture-Backed Buyouts at Record Volume as Increasing Pace of Exits Mark Possible Recovery 01/03/11 National
Epocrates Re-files for IPO 07/19/10 San Francisco
Filing: Webfilings Adds $5.1M 07/12/10 San Francisco
Sequenom Meets With FBI, U.S. Attorney’s Office Investigators 10/05/09 San Diego
SEC Charges CellCyte With Stem Cell Fraud 09/08/09 Seattle
CellCyte Settles SEC Investigation 05/18/09 Seattle
Amylin Resurrects Obesity Drug, in New Combination with Diabetes Drug Symlin 10/04/08 San Diego
Page 1 of 1